Company profile CELC
After 39 days of this quarter the interest is at 77.0. Based on that we can calculate that during remaining 52 days it will total up to 180.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 68 | 111 63.2% QoQ | 138 24.3% QoQ | 45 -67.4% QoQ |
| 2020 | 114 67.6% YoY 153.3% QoQ | 92 -17.1% YoY -19.3% QoQ | 51 -63.0% YoY -44.6% QoQ | 103 128.9% YoY 102.0% QoQ |
| 2021 | 96 -15.8% YoY -6.8% QoQ | 212 130.4% YoY 120.8% QoQ | 208 307.8% YoY -1.9% QoQ | 223 116.5% YoY 7.2% QoQ |
| 2022 | 84 -12.5% YoY -62.3% QoQ | 218 2.8% YoY 159.5% QoQ | 180 -13.5% YoY -17.4% QoQ | 127 -43.0% YoY -29.4% QoQ |
| 2023 | 146 73.8% YoY 15.0% QoQ | 135 -38.1% YoY -7.5% QoQ | 183 1.7% YoY 35.6% QoQ | 137 7.9% YoY -25.1% QoQ |
| 2024 | 77 -47.3% YoY -43.8% QoQ | - | - | - |
The average 5 years interest of Celcuity was 10.53 per week. The last year interest of Celcuity compared to the last 5 years has changed by 23.84%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 69.13%.
There is not enough data for Celcuity cancer therapy to provide analysis
There is not enough data for Celcuity cancer therapy to provide correlation calculation
There is not enough data for Celcuity cancer therapy to provide analysis
There is not enough data for CELsignia diagnostic platform to provide analysis
There is not enough data for CELsignia diagnostic platform to provide correlation calculation
There is not enough data for CELsignia diagnostic platform to provide analysis
There is not enough data for Gedatolisib breast cancer to provide analysis
There is not enough data for Gedatolisib breast cancer to provide correlation calculation
There is not enough data for Gedatolisib breast cancer to provide analysis
There is not enough data for Celcuity MP test to provide analysis
There is not enough data for Celcuity MP test to provide correlation calculation
There is not enough data for Celcuity MP test to provide analysis
After 39 days of this quarter the interest is at 129.0. Based on that we can calculate that during remaining 52 days it will total up to 301.0. Celcuity stock expected interest is significantly higher compared to previous quarter (+2910.0%) and same quarter last year (+600.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 9 | 68 655.6% QoQ | 25 -63.2% QoQ | 24 -4.0% QoQ |
| 2020 | 37 311.1% YoY 54.2% QoQ | 45 -33.8% YoY 21.6% QoQ | 0 -100.0% YoY -100.0% QoQ | 86 258.3% YoY inf% QoQ |
| 2021 | 85 129.7% YoY -1.2% QoQ | 93 106.7% YoY 9.4% QoQ | 43 inf% YoY -53.8% QoQ | 33 -61.6% YoY -23.3% QoQ |
| 2022 | 45 -47.1% YoY 36.4% QoQ | 26 -72.0% YoY -42.2% QoQ | 31 -27.9% YoY 19.2% QoQ | 11 -66.7% YoY -64.5% QoQ |
| 2023 | 43 -4.4% YoY 290.9% QoQ | 36 38.5% YoY -16.3% QoQ | 46 48.4% YoY 27.8% QoQ | 10 -9.1% YoY -78.3% QoQ |
| 2024 | 129 200.0% YoY 1190.0% QoQ | - | - | - |
The average 5 years interest of Celcuity stock was 3.54 per week. The last year interest of Celcuity stock compared to the last 5 years has changed by 27.12%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 50.0%.
There is not enough data for Celcuity clinical trials to provide analysis
There is not enough data for Celcuity clinical trials to provide correlation calculation
There is not enough data for Celcuity clinical trials to provide analysis
There is not enough data for Celcuity careers to provide analysis
There is not enough data for Celcuity careers to provide correlation calculation
There is not enough data for Celcuity careers to provide analysis
There is not enough data for Celcuity reviews to provide analysis
There is not enough data for Celcuity reviews to provide correlation calculation
There is not enough data for Celcuity reviews to provide analysis
There is not enough data for Celcuity Minnesota to provide analysis
There is not enough data for Celcuity Minnesota to provide correlation calculation
There is not enough data for Celcuity Minnesota to provide analysis